Amgen at AAPS 2026 PharmSci 360
Oct 25–28, 2026 New Orleans, LA ~4k attendees Website
Amgen brings 4 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program centres on GLP-1 medicines, from new delivery systems to antibodies built for anti-drug antibody tests. Its sessions also cover a risk-based approach to filling recipes in fill and finish manufacturing.
| Organization | AAPS 2026 PharmSci 360 Attendance |
|---|---|
Amgen Thousand Oaks, CA | |
Global biopharmaceutical company developing and marketing medicines in oncology, inflammation, cardiovascular and bone disease. | Poster Mon Oct 26 12:30pm–1:30pm A Risk Based Design Space Methodology for Developing Baseline Filling Recipes in Drug Product Fill/Finish Manufacturing Poster Tue Oct 27 12:30pm–1:30pm Generation, Screening, and Characterization of Anti‑GLP‑1 Mutein Monoclonal Antibodies for Anti-Drug Antibody and Neutralizing Antibody Assays Talk Wed Oct 28 9:00am–10:00am Talk Wed Oct 28 9:00am–9:30am |
Instantly find 20 buyers from Amgen
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction